Clinical Trial

Cohort-Based Study of Diagnostic Biomarkers for Neurosyphilis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to identify diagnostic biomarkers for neurosyphilis in patients with the condition. The main questions it aims to answer are: What plasma biomarkers are associated with neurosyphilis? What electrophysiological characteristics (EEG and eye movement) are linked to neurosyphilis? Researchers will compare biomarker data from plasma and gut microbiome analyses with electrophysiological findings to see if these factors can help diagnose neurosyphilis. Participants will: Provide clinical information such as age, gender, symptoms, and disease course Submit blood and urine samples for proteomics and metagenomic sequencing Undergo EEG and eye movement evaluations for electrophysiological analysis
Trial Details
NCT Number NCT06680011
Lead Sponsor Shanghai Mental Health Center
Conditions Neurosyphilis, Biomarkers, Proteomics
Enrollment 360 participants
Start Date 2024-04-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2024-11-08